The 25th Shanghai International Forum on Biotechnology and Pharmaceutical Industry commenced in Pudong on June 13, boasting the theme of "Leveraging Innovative Resource Advantages and Building a High Ground for R&D Economy". Over 200 experts from across the globe attended the event.

High-level executives and renowned academics from various countries delivered keynote speeches throughout the forum, offering a comprehensive examination of the development of innovation in biomedicine and discussing emerging advances and prospects in numerous cutting-edge research fields.

Moreover, two exclusive forums delved into revolutionary biomedicinal technologies and related financial services. Expert discussions encompassed the future of artificial intelligence in biomedicine and the role of financial services in bolstering the biopharmaceutical industry.

Running concurrently was the 13th Shanghai Medical Equipment and Biotechnology Exhibition, which drew the participation of nearly 50 enterprises. Spanning an area of approximately 3,000 square meters, the exhibition fostered collaboration and innovation among medical, industrial, academic, and research entities.

From June 14 to 15, the conference held 14 sub-forums, diving into topics such as advanced cell therapy technologies and pioneering synthetic biology applications. Furthermore, the sub-forums addressed crucial industry themes like the development of the biopharmaceutical innovation ecosystem in the Yangtze River Delta region and innovation-driven drug development underpinned by clinical demand.

The 25th Shanghai International Forum on Biotechnology and Pharmaceutical Industry opens in Pudong on June 13. [Photo/WeChat account: pdnews]